The rising tide of drug-resistant infections and dearth of new antibiotics calls for the same kind of urgency and action as the HIV/AIDs epidemic, says Laura Piddock, founder of Antibiotic Action
UCL is today inaugurating a new Quantum Science & Technology Institute (UCLQ). The new institute will coordinate and support research into quantum science and technology across UCL, helping to develop this fast-advancing field of research.
Study shows little progress in bridging the gap between the world’s networked economies and rest of world; Nordic countries dominate Networked Readiness Index, while emerging markets struggle most in realising digital potential
After the first launch in April, the European Space Agency’s new Copernicus earth observation system has just begun to beam back images. This will be a spur for innovation, says project coordinator Josef Aschbacher
ATTRACT brings science development to open innovation in products and services in industry, education, research and policy. The project is currently seeking potential partners.
The economic significance of patents ranges from impacts on growth and global trade, to patent portfolio management within firms. The EU could do more to extract value from its patent store, says Theon van Dijk, Chief Economist, European Patent Office
Georgios Stavropoulos, a physicist in Greece’s Institute of Nuclear and Particle Physics, is pitching for his frontier deep sea neutrino project to be included under the EU’s new experimental regional funding scheme
Germany’s ambitious Energiewende made it the world’s largest energy lab. But with CO2 emissions up and electricity prices rising, the programme’s value as a blueprint for others is limited, says Stephan Reimelt, president and CEO of GE Energy, Germany.
Imperial Innovations' portfolio company, Oxford Immunotec Global PLC (NASDAQ: OXFD), has received a Queen’s Award for Enterprise – the UK’s highest accolade in business success.
With the Eurostars’ funding pot replenished by nearly €1.2B, EUREKA chairwoman Kristin Danielsen shares her thoughts on its importance for small businesses in Europe
Next generation of public-public research programmes in fields of clinical trials, SME financing, active ageing and metrology among initiatives that received green light from MEPs
As resistance to traditional antibiotics reaches crisis levels, scientists are poised to forage in hard-to-reach sea trenches for new antimicrobials and novel compounds that could provide the basis of new drugs
A team of researchers from five Swedish universities, led by Karolinska Institutet and the Science for Life Laboratory, have identified a new way of treating cancer. The concept is presented in the journal Nature and is based on inhibiting a specific enzyme called MTH1, which cancer cells, unlike normal cells, require for survival. Without this enzyme, oxidized nucleotides are incorporated into DNA, resulting in lethal DNA double-strand breaks in cancer cells.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.